Orthopedic Expertise Stelkast has a strong legacy in manufacturing implants for major orthopedic firms, backed by three decades of metallurgical and engineering leadership, positioning it as a key partner for custom implant solutions and innovative joint replacement products.

Recent Acquisition The company's assets were acquired by Globus Medical in 2019 for approximately $24.1 million, indicating potential opportunities to collaborate on new product development and integration within Globus’s expanding orthopedic portfolio.

Growth Potential With annual revenues estimated between $1 million and $10 million and a focused product line of knee and hip implants, there is room to expand sales through targeted outreach to hospitals and orthopedic clinics seeking reliable implant suppliers.

Innovative Approach Stelkast's continuous emphasis on innovation, driven by clinician input and advanced engineering, suggests potential for partnerships in cutting-edge implant technologies and customized orthopedic solutions tailored to evolving market trends.

Market Position As a smaller specialized manufacturer with a niche market, StelKast provides opportunities for personalized service and collaboration with healthcare providers seeking high-quality, innovative implant options that differentiate from larger competitors.